Herpes simplex virus reactivation among hematopoietic stem cell transplant recipients: re-evaluating acyclovir dosage

Bone Marrow Transplant. 2024 Jul;59(7):1043-1045. doi: 10.1038/s41409-024-02273-8. Epub 2024 Apr 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acyclovir* / administration & dosage
  • Acyclovir* / therapeutic use
  • Adult
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Female
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Herpes Simplex*
  • Humans
  • Male
  • Middle Aged
  • Simplexvirus* / drug effects
  • Virus Activation* / drug effects

Substances

  • Acyclovir
  • Antiviral Agents